New treatment Xadago to help 100,000 Canadians living with Parkinson’s

News

Author: Parkinson's Life editorsPublished: 5 May 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

More than 100,000 Canadians living with Parkinson’s will benefit from a new product to be launched in the country.

The drug known as ‘Xadago’, currently readily available in several countries across Europe, helps control motor symptoms and complications over a 24-month period.

Xadago will be the first new oral treatment for Parkinson’s in almost 15 years in Canada. On 21 March 2017 the Food and Drug Administration in the US approved the use of Xadago for the treatment of Parkinson’s as an add-on therapy to levodopa/carbidopa.

Go Back

Share this story

Comments


Related articles


Billy Connolly receiving knighthood

Perspectives

Arise, Sir Billy Connolly

Billy Connolly receives a knighthood

READ MORE
New to Parkinson's video lead

Resources & Tools

VIDEO: “No one with Parkinson’s should feel alone”

Video: Parkinson’s communities share experiences of the condition

READ MORE
little-owl-in-flight

Perspectives

6 more world-class wildlife stills from a photographer with Parkinson’s

David Plummer shares more of his top photographs of wildlife in action

READ MORE